NORBIT ASA – Mandatory notification of trade by primary insider 

Trondheim, 4 September 2026

Petors AS, a company wholly owned by Per Jørgen Weisethaunet, CEO of NORBIT ASA, has today purchased 3,100 shares in NORBIT ASA at an average price of NOK 159.288 per share.

Following the transaction, Petors AS holds 7,015,735 shares. Weisethaunet and his closely associated persons hold a total of 7,018,366 shares in the company, representing approximately 10.95% of the company’s outstanding shares.

Please see the attached notification for persons discharging managerial responsibilities in NORBIT in accordance with Regulation EU 596/2014 (MAR) article 19.

About NORBIT ASA
NORBIT is a global provider of tailored technology to selected applications, solving challenges and promoting sustainability through innovative solutions, in line with its mission to Explore More. The company is structured in three business segments to address its key markets: Oceans, Connectivity and Product Innovation & Realization. The Oceans segment delivers tailored technology solutions to global maritime markets. The Connectivity segment provides wireless solutions for identification, monitoring and tracking. The Product Innovation & Realization segment offers R&D services, proprietary products, and contract manufacturing to key customers. NORBIT is headquartered in Trondheim with manufacturing in Europe and North America, has around 750 employees, and a worldwide sales and distribution platform.

For more information: www.norbit.com

This information is subject to the disclosure requirements in Regulation EU 596/2014 (MAR) article 19 and the Norwegian Securities Trading Act § 5 -12.

The information was submitted for publication by Elise Heidenreich, Investor Relations at NORBIT ASA, on 4 September 2026 at 11:25 CEST.

Attachment

• 260904 PDMR Per Jorgen Weisethaunet

You May Also Be Interested In

• Crypto Price Today - Could Bitcoin’s 40% Rebound Signal a New Bull Run? As Apeing’s Crypto Presale Begins in 5 Days
• AKD Signs Exclusive License to Bring Binaxity's Asset-Backed Lending Platform to US Institutions
• Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress